ListarMD - Artículos por tema "Recurrent ovarian cancer"
Mostrando ítems 1-1 de 1
-
Bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer
(KARGER, 2010-11)Aim: To retrospectively assess the efficacy and safety of bevacizumab plus low-dose metronomic oral cyclophosphamide in heavily pretreated patients with recurrent ovarian cancer. Patients and Methods: Patients with recurrent ...